
Acm Research (ACMR) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
215.4M
Gross Profit
104.5M
48.50%
Operating Income
31.7M
14.72%
Net Income
36.3M
16.84%
EPS (Diluted)
$0.44
Balance Sheet Metrics
Total Assets
1.9B
Total Liabilities
778.4M
Shareholders Equity
1.2B
Debt to Equity
0.67
Cash Flow Metrics
Operating Cash Flow
8.3M
Free Cash Flow
-11.8M
Revenue & Profitability Trend
Acm Research Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 782.1M | 557.7M | 388.8M | 259.8M | 156.6M |
Cost of Goods Sold | 390.6M | 281.5M | 205.2M | 144.9M | 87.0M |
Gross Profit | 391.6M | 276.2M | 183.6M | 114.9M | 69.6M |
Gross Margin % | 50.1% | 49.5% | 47.2% | 44.2% | 44.4% |
Operating Expenses | |||||
Research & Development | 105.5M | 92.7M | 62.2M | 34.2M | 19.1M |
Selling, General & Administrative | 135.1M | 87.7M | 62.4M | 41.9M | 29.0M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 240.6M | 180.4M | 124.6M | 76.2M | 48.1M |
Operating Income | 151.0M | 95.8M | 59.0M | 38.7M | 21.5M |
Operating Margin % | 19.3% | 17.2% | 15.2% | 14.9% | 13.7% |
Non-Operating Items | |||||
Interest Income | 9.9M | 8.4M | 8.7M | 505.0K | 897.0K |
Interest Expense | 4.2M | 2.7M | 1.7M | 765.0K | 982.0K |
Other Non-Operating Income | 9.5M | 14.7M | 1.2M | 4.6M | -2.1M |
Pre-tax Income | 166.3M | 116.2M | 67.4M | 43.1M | 19.3M |
Income Tax | 35.0M | 19.4M | 16.8M | 134.0K | -2.4M |
Effective Tax Rate % | 21.1% | 16.7% | 24.9% | 0.3% | -12.3% |
Net Income | 131.3M | 96.9M | 50.6M | 42.9M | 21.7M |
Net Margin % | 16.8% | 17.4% | 13.0% | 16.5% | 13.8% |
Key Metrics | |||||
EBITDA | 177.7M | 120.7M | 81.1M | 45.6M | 8.8M |
EPS (Basic) | $1.67 | $1.29 | $0.66 | $0.65 | $0.34 |
EPS (Diluted) | $1.53 | $1.16 | $0.59 | $0.58 | $0.30 |
Basic Shares Outstanding | 62212569 | 60164670 | 59235975 | 57654708 | 54700083 |
Diluted Shares Outstanding | 62212569 | 60164670 | 59235975 | 57654708 | 54700083 |
Income Statement Trend
Acm Research Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 407.4M | 182.1M | 248.0M | 562.5M | 71.8M |
Short-term Investments | 36.6M | 101.8M | 90.7M | 29.5M | 28.2M |
Accounts Receivable | 387.0M | 283.2M | 182.9M | 105.6M | 56.4M |
Inventory | 598.0M | 545.4M | 393.2M | 218.1M | 88.6M |
Other Current Assets | - | - | - | - | - |
Total Current Assets | 1.5B | 1.2B | 963.8M | 952.9M | 260.7M |
Non-Current Assets | |||||
Property, Plant & Equipment | 51.1M | 23.6M | 11.8M | 12.2M | 10.3M |
Goodwill | 3.5M | 10.9M | 9.9M | 10.9M | 11.0M |
Intangible Assets | 3.5M | 10.9M | 9.9M | 10.9M | 11.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 16.8M | 21.4M | 7.9M | 14.4M | 11.4M |
Total Non-Current Assets | 372.3M | 314.8M | 271.7M | 99.2M | 80.6M |
Total Assets | 1.9B | 1.5B | 1.2B | 1.1B | 341.3M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 139.3M | 141.8M | 101.7M | 93.5M | 35.6M |
Short-term Debt | 79.4M | 40.9M | 59.7M | 14.3M | 29.2M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 641.2M | 500.7M | 396.2M | 205.9M | 102.9M |
Non-Current Liabilities | |||||
Long-term Debt | 109.4M | 58.2M | 19.8M | 24.8M | 20.9M |
Deferred Tax Liabilities | - | - | 0 | 1.3M | 1.3M |
Other Non-Current Liabilities | 1.2M | 1.3M | 1.7M | 684.0K | 4.2M |
Total Non-Current Liabilities | 118.6M | 64.1M | 27.1M | 34.6M | 30.2M |
Total Liabilities | 759.8M | 564.7M | 423.3M | 240.5M | 133.1M |
Equity | |||||
Common Stock | 7.0K | 7.0K | 6.0K | 6.0K | 2.0K |
Retained Earnings | 260.0M | 156.8M | 94.4M | 63.7M | 34.3M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.1B | 926.2M | 812.2M | 811.7M | 208.2M |
Key Metrics | |||||
Total Debt | 188.8M | 99.1M | 79.5M | 39.1M | 50.0M |
Working Capital | 842.1M | 675.5M | 567.6M | 747.0M | 157.7M |
Balance Sheet Composition
Acm Research Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 131.3M | 96.9M | 50.6M | 42.9M | 21.7M |
Depreciation & Amortization | 10.0M | 8.1M | 5.4M | 2.4M | 1.1M |
Stock-Based Compensation | 49.6M | 27.3M | 7.7M | 5.1M | 5.6M |
Working Capital Changes | -113.3M | -210.3M | -163.4M | -91.3M | -39.6M |
Operating Cash Flow | 86.6M | -88.0M | -92.9M | -40.2M | -3.3M |
Investing Activities | |||||
Capital Expenditures | -82.5M | -61.9M | -91.1M | -9.2M | -45.4M |
Acquisitions | - | - | -1.0M | -1.6M | 0 |
Investment Purchases | -101.0M | -52.0M | -177.7M | -1.6M | -15.0M |
Investment Sales | 175.0M | 109.6M | 4.6M | 0 | 0 |
Investing Cash Flow | -8.5M | -4.3M | -437.7M | -12.3M | -60.4M |
Financing Activities | |||||
Share Repurchases | - | - | - | 0 | 0 |
Dividends Paid | -6.9M | -4.0M | 0 | 0 | - |
Debt Issuance | 96.9M | 42.4M | 0 | 7.1M | 19.7M |
Debt Repayment | -41.9M | -57.4M | -11.4M | -41.9M | -22.2M |
Financing Cash Flow | 49.1M | -42.7M | 35.3M | 493.7M | 9.9M |
Free Cash Flow | 66.5M | -139.7M | -154.7M | -49.8M | -69.0M |
Net Change in Cash | 127.2M | -135.0M | -495.3M | 441.2M | -53.9M |
Cash Flow Trend
Acm Research Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.17
Forward P/E
12.92
Price to Book
1.64
Price to Sales
1.98
PEG Ratio
0.74
Profitability Ratios
Profit Margin
13.76%
Operating Margin
14.72%
Return on Equity
12.68%
Return on Assets
4.91%
Financial Health
Current Ratio
2.45
Debt to Equity
24.12
Beta
1.35
Per Share Data
EPS (TTM)
$1.66
Book Value per Share
$15.39
Revenue per Share
$12.91
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
acmr | 1.6B | 15.17 | 1.64 | 12.68% | 13.76% | 24.12 |
Applied Materials | 131.7B | 19.59 | 6.72 | 35.63% | 23.88% | 32.11 |
Lam Research | 125.1B | 23.82 | 12.72 | 58.24% | 29.07% | 48.23 |
Kulicke & Soffa | 1.9B | 406.67 | 2.29 | 0.66% | 0.90% | 4.34 |
Veeco Instruments | 1.5B | 23.81 | 1.71 | 7.71% | 8.65% | 30.69 |
Photronics | 1.3B | 10.91 | 1.12 | 11.93% | 14.00% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.